GLP-1 drugs may influence chronic pain through gut-brain and immune pathways
From microbial metabolites and spinal microglia to osteoarthritis and headache trials, researchers map how GLP-1 signaling intersects with…
Tirzepatide vs semaglutide for asthma: the difference was smaller than researchers expected
Researchers compared two widely used incretin therapies in more than 16,000 matched adults with asthma and type 2…
Digital companion apps help secure long-term habits during GLP-1 therapy
Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant…
GLP-1 drugs appear psychiatrically safe, but one finding still raises questions
With millions of patients now taking GLP-1 drugs, researchers examined whether concerns about depression and suicidality are supported…
Mouse study shows how liraglutide briefly rewires gut bacterial communities
A mouse study tracks how a leading GLP-1 drug alters gut bacteria over time, offering new clues to…
Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits
A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
Semaglutide dose may matter more than weight loss for heart health
A large real-world study suggests semaglutide’s cardiovascular benefits may be more closely linked to the dose patients receive…
Gut microbiota may shape eating behavior and guide new obesity treatments
From appetite signals to food reward, researchers reveal how gut microbes may influence disordered eating and obesity, while…
GLP-1 medicines may cut clot-related risks in chronically inflamed patients
A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed,…
Scientists rethink GLP-1 delivery to improve dosing, tolerability, and adherence
From microneedles to nanocarriers, researchers are rethinking how GLP-1 medicines could become longer-lasting, easier to tolerate, and more…
People judge GLP-1 users more harshly than dieters
Even as GLP-1 medications transform obesity treatment, new research reveals a surprising reality: people may face stigma whether…